Science / Reel
Science · Video brief
FDA panel considers a first-of-its-kind flu vaccine using mRNA technology
Discover how mRNA technology is revolutionizing flu prevention with Moderna's new vaccine, mFlusiva. Targeted at those 50 and older, this vaccine promises quicker production and better efficacy against flu mutations. Learn about the controv...
Video won't play? Watch on YouTube →
Discover how mRNA technology is revolutionizing flu prevention with Moderna's new vaccine, mFlusiva. Targeted at those 50 and older, this vaccine promises quicker production and better efficacy against flu mutations. Learn about the controversies and the potential impact as experts evaluate its effectiveness. #mRNA #FluVaccine #Moderna #FDA #HealthInnovation
Originally reported by The Guardian.
Read the full story →
More in Science
Science
Scien
Science
The Guardian view on Trump’s MMR executive order: endangering the children he claims to care about | Editorial
Science
Scien
Science
Imran Khan’s family and party say Pakistan violated court order by taking him to government hospital
Science
Scien
Science
0 Comments
No comments yet. Be the first.